2025 Autonomic Disorders Reading List

Reading List

Please click below to access the 2025 Autonomic Disorders reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Recommend fluid and tissue biomarkers that may aid in the diagnosis and differentiation of various autonomic disorders
• Apply testing modalities in the patient population to more quickly provide accurate diagnosis and prognosis to patients with autonomic dysfunction and failure
• Prescribe treatment modalities that serve the patient population experiencing autonomic syndromes, including POTS, vasovagal syncope, and orthostatic hypertension

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2025 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Autonomic Disorders Certification Examination Committee Contributors

Elizabeth Coon, MD, Chair, Mayo Clinic – Rochester 
Disclosures: Nothing to disclose.

Satish Raj, MD, Vice Chair, University of Calgary
Disclosures: Received compensation for serving as consultant to Theravance Biopharma, Amneal Pharma, Servier Affaires Medicales, Regeneron, argenx BV, Antag Pharma, and STAT Health; received compensation as Associate Editor, Autonomic Neurosciences; receive research support from Canadian Institutes of Health Research Heart & Stroke Foundation of Canada Dysautonomia International Standing Up To POTS Canerector Foundation.

Srikanth Muppidi, MD, Stanford Neuroscience Health Center
Disclosures: Nothing to disclose.

Melissa M. Cortez, DO, University of Utah Health
Disclosures: Received compensation for serving on scientific advisory or data safety monitoring board for NIH RECOVER Initiative (clinical trials DSMB); received research support from NIH NINDS, Dysautonomia International. 

Elisabeth Golden, MD, UT Southwestern
Disclosures: Received compensation from The Dysautonomia Project; received honoraria for speaking and for serving as faculty of The Residents Course; received compensation for Medical Advisor List for The Dysautonomia Project.

Nathaniel Robbins, MD, Mass General / Brigham
Disclosures: Received consulting compensation from Clarityco Strategic Group, Inc, Red Nucleus, TDG Health, Jupiter Life Science Consulting; received compensation for serving as expert witness for DOJ, DHHS; received research support from Dysautonomia International Vertex pharmaceutical INC Ethnoinstitute.

Howard Snapper, MD, WellStar Medical Group
Disclosures: Nothing to disclose.

Kamal Shouman, MD, Mayo Clinic – Rochester 
Disclosures: Nothing to disclose.

Meredith Bryarly, MD, UT Southwestern Medical Center
Disclosures: My husband currently owns stock options greater than $10,000 in ARDX, ALT, and AKRO; receive research support from Theravance Biopharma.

Gisela G. Chelimsky, MD, Virginia Commonwealth University
Disclosures: Received compensation for legal consulting; spouse received compensation from NIH; myself and my husband have received compensation as expert witnesses; received research grant from AHRQ; spouse received compensation from Duke University; serve for the American Board of Pediatrics writing board questions for pediatric gastroenterology subcommittee.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326